BioEurope Spring

Milan, Italy

17 – 19 March 2025

Let’s meet at Bio Europe 29th Annual International Partnering Conference !

Axoltis Pharma is developing an innovative drug for CNS diseases. NX210c, with a good safety profile, can be a breakthrough therapy for neurodegenerative diseases, restoring the impaired blood-brain barrier integrity, as observed in our preclinical and clinical trials.